CRISPR could help doctors attack blood cancer without destroying healthy cells
Researchers used CRISPR to remove CD33 from donor stem cells, potentially giving doctors a way to attack aggressive blood cancers without destroying the healthy cells patients need after a transplant. In a 30-patient trial, the edited cells successfully took hold and appeared to shield blood cells from a CD33-targeted cancer treatment.
We haven't written up this one. ScienceDaily has the full story — the link below goes straight to it.
